Page last updated: 2024-08-21

vancomycin and ceftobiprole

vancomycin has been researched along with ceftobiprole in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (59.38)	29.6817
2010's	10 (31.25)	24.3611
2020's	3 (9.38)	2.80

Authors

Authors	Studies
Arias, CA; Murray, BE; Panesso, D; Singh, KV	1
Amsler, K; Heep, M; Noel, GJ; Pypstra, R; Solomkin, JS; Strauss, RS	1
Calhoun, JH; Schmitt-Hoffmann, A; Shapiro, S; Thomas, JK; Yin, LY	1
Laohavaleeson, S; Nicolau, DP; Tessier, PR	1
Chang, KY; Ho, YH; Hsieh, YC; Hsueh, PR; Huang, LM; Huang, YC; Lin, HC	1
Lombardo, F; Obach, RS; Waters, NJ	1
Antignac, A; Chung, M; Kim, C; Tomasz, A	1
Cheung, CM; Leonard, SN; Rybak, MJ	1
Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W	1
Duval, V; Glupczynski, Y; Joris, B; Lemaire, S; Tulkens, PM; Van Bambeke, F	1
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C	1
Abbanat, D; Bush, K; Fernandez, J; Flamm, RK; Hilliard, JJ; Melton, JL; Santoro, CM; Zhang, W	1
Basuino, L; Bauer, D; Chambers, HF; Diep, BA; Tattevin, P	1
Chambers, HF	1
Bento, M; Gjinovci, A; Lew, DP; Li, D; Schrenzel, J; Vaudaux, P	1
Appelbaum, PC	1
Loffler, CA; Macdougall, C	1
Decker, CF; Johnson, MD	1
Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG	1
Bagchi, P; Kimko, H; Nandy, P; Noel, GJ; Samtani, MN; Strauss, RS; Xu, X	1
Eliopoulos, GM	1
Chahine, EB	1
Daubner, B; Pichler, WJ; Wendland, T	1
Entenza, JM; Giddey, M; Majcherczyk, P; Moreillon, P; Veloso, TR; Vouillamoz, J	1
Andes, DR; Craig, WA; Lee, DG; Murakami, Y	1
Beaume, M; Francois, P; Harrison, PF; Hernandez, D; Howden, BP; Schrenzel, J; Seemann, T; Stinear, TP	1
Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG	1
Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS	1
Holmes, NE; Howden, BP	1
Engelhardt, M; Gonzalez-Rojas, Y; Gumenchuk, I; Hamed, KA; Ionescu, D; Jones, ME; Keech, R; Kim, C; Ninov, B; Overcash, JS; Saulay, M; Simeonov, S; Smart, JI; Waters, M	1
Bosheva, M; Gujabidze, R; Hamed, KA; Károly, É; Nemeth, A; Saulay, M; Smart, JI	1
Chatre, C; Dunyach-Remy, C; Lavigne, JP; Pantel, A; Pouget, C; Reynes, J	1

Reviews

4 review(s) available for vancomycin and ceftobiprole

Article	Year
MRSA--the tip of the iceberg. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2006, Volume: 12 Suppl 2 Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Community-Acquired Infections; Gram-Positive Bacteria; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2006
Antimicrobial agents in treatment of MRSA infections. Disease-a-month : DM, 2008, Volume: 54, Issue:12 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Community-Acquired Infections; Daptomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tetracyclines; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin	2008
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. The Journal of infection, 2009, Volume: 59 Suppl 1 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Teicoplanin; Vancomycin	2009
What's new in the treatment of serious MRSA infection? Current opinion in infectious diseases, 2014, Volume: 27, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Cost-Benefit Analysis; Drug Administration Routes; Drug Therapy, Combination; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Severity of Illness Index; Skin Diseases, Bacterial; Staphylococcal Infections; Tetrazoles; Vancomycin	2014

Trials

4 trial(s) available for vancomycin and ceftobiprole

Article	Year
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Double-Blind Method; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Male; Middle Aged; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin	2008
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus	2008
Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7 Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Double-Blind Method; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Treatment Outcome; Vancomycin	2021
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients. The Pediatric infectious disease journal, 2021, 06-01, Volume: 40, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin	2021

Other Studies

24 other study(ies) available for vancomycin and ceftobiprole

Article	Year
Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Synergism; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Streptomycin; Vancomycin Resistance	2007
Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:5 Topics: Animals; Body Weight; Cephalosporins; Disease Models, Animal; Methicillin Resistance; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tibia	2008
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus	2008
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Taiwan	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2008
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2008
Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Anti-Bacterial Agents; Cell Line; Cephalosporins; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Keratinocytes; Macrophages; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phagocytosis; Ribonucleoproteins; Saccharomyces cerevisiae Proteins; Staphylococcus aureus	2009
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance	2009
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Immunocompromised Host; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Hairless; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus	2010
Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:2 Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Daptomycin; Disease Models, Animal; Endocarditis, Bacterial; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rabbits; Random Allocation; Vancomycin	2010
Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:3 Topics: Animals; Aortic Valve; Cephalosporins; Disease Models, Animal; Endocarditis, Bacterial; Heart Valve Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2005
Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:9 Topics: Animals; Cephalosporins; Foreign Bodies; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2005
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:6 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin	2007
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance	2009
Pharmacodynamic profiling of ceftobiprole for treatment of complicated skin and skin structure infections. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Skin Diseases, Infectious; Treatment Outcome; Vancomycin	2009
Ceftobiprole: Farewell or just a delay? American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010, Jun-15, Volume: 67, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Approval; Humans; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; United States; United States Food and Drug Administration; Vancomycin	2010
Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin. British journal of clinical pharmacology, 2011, Volume: 71, Issue:2 Topics: Aged; Agranulocytosis; Anti-Bacterial Agents; Cephalosporins; Drug Eruptions; Drug Therapy, Combination; Eosinophilia; Female; Humans; Rifampin; Syndrome; Vancomycin	2011
In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:9 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Endocarditis; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin	2011
Inoculum effects of ceftobiprole, daptomycin, linezolid, and vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 10(5) and 10(7) CFU injected into opposite thighs of neutropenic mice. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Daptomycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Subcutaneous; Linezolid; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Oxazolidinones; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Thigh; Vancomycin	2013
Analysis of the small RNA transcriptional response in multidrug-resistant Staphylococcus aureus after antimicrobial exposure. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:8 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Protein Biosynthesis; RNA, Bacterial; RNA, Messenger; RNA, Small Untranslated; Sequence Analysis, RNA; Tigecycline; Transcription, Genetic; Vancomycin	2013
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus. Clinical and experimental pharmacology & physiology, 2014, Volume: 41, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin	2014
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types. International journal of antimicrobial agents, 2014, Volume: 43, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Vancomycin	2014
Effect of Antibiotic Exposure on International journal of molecular sciences, 2023, Jan-12, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Bacteremia; Biofilms; Catheters; Daptomycin; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin	2023